# Journal Submission Verification Checklist

**Project:** Evidence-Conditioned Compositional Pipeline Synthesis: A Provenance-Aware Framework for Reproducible Clinical Machine Learning  
**Date of Audit:** September 02, 2026  
**Scientific Verdict:** Grade A — Submission-Ready  
**Test Suite Status:** 720 / 720 Backend Tests Passed (100%)  

---

### Phase A: Manuscript Files & Display Items
- [x] **Manuscript PDF:** `final_research_paper.pdf` (15 pages, 300 DPI figures embedded, no clipping, no blank pages)
- [x] **Source Manuscript:** `final_research_paper.md` (3,987 words, formatted in GitHub Markdown)
- [x] **High-Resolution Figures (8 items):**
  - [x] Figure 1: Pipeline Synthesis Architecture (`fig1_pipeline_architecture.png` / `.svg`)
  - [x] Figure 2: Candidate vs Baseline Predictive Performance (`fig2_baseline_performance.png` / `.svg`)
  - [x] Figure 3: Multi-Seed Robustness & Seed 100 Dynamics (`fig3_per_seed_robustness.png` / `.svg`)
  - [x] Figure 4: Controlled Component Ablation Analysis (`fig4_component_ablation.png` / `.svg`)
  - [x] Figure 5: Probability Calibration Comparison (`fig5_calibration_comparison.png` / `.svg`)
  - [x] Figure 6: Candidate Multi-Metric Profile (`fig6_multi_metric_profile.png` / `.svg`)
  - [x] Figure 7: Component Provenance Ledger & Boundary (`fig7_provenance_boundary.png` / `.svg`)
  - [x] Figure 8: Formal Scientific Claim Boundary Matrix (`fig8_claim_boundary_matrix.png` / `.svg`)
- [x] **Structured Summary Tables (3 items):**
  - [x] Table 1: Primary Predictive Performance (Mean ± Std across seeds)
  - [x] Table 2: Per-Seed Robustness & Seed 100 Breakdown
  - [x] Table 3: Controlled Component Ablation Results

---

### Phase B: Pre-Submission Documentation & Metadata
- [x] **Cover Letter:** `cover_letter.md` (Methodological focus, conservative framing, reproducibility compliance)
- [x] **Submission Metadata:** `submission_metadata.json` & `submission_metadata.md`
- [x] **Journal Targeting Analysis:** `journal_targeting.md` (JBI primary target, JAMIA secondary)
- [x] **Data Availability Statement:** Explicitly provided in manuscript and metadata
- [x] **Code Availability Statement:** Open-source repository link and test verification commands provided
- [x] **Author & Institutional Placeholders:** Standardized placeholders (`AUTHOR_NAME_PLACEHOLDER`, `AFFILIATION_INSTITUTION_PLACEHOLDER`) without fabricated details
- [x] **Funding & COI Statements:** Standardized placeholders ready for author completion
- [x] **Ethics Statement:** De-identified secondary data exemption statement included

---

### Phase C: Scientific Integrity & Forensic Invariants
- [x] **Operational Tabular Imputation Disclosed:** Train-fitted univariate median/mode imputation documented as actual executor
- [x] **Multimodal Primitives Formally Dormant:** `cross_attention` and `average_ensembling` classified as dormant taxonomy capabilities
- [x] **Post-Adjuvant Prediction Epoch Defined:** Temporal window explicitly anchored; `progress_1` prospective caveat documented
- [x] **Baseline Fairness Enforced:** Simple MLP (`max_iter=10`) characterized as minimal shallow reference comparator
- [x] **Statistical Underpowering Disclosed:** Sample size of $n=3$ seeds acknowledged; $p$-values suppressed
- [x] **Seed 100 Candidate Loss Disclosed:** `0.9609` vs `0.9643` ($-0.0034$ delta) transparently reported
- [x] **Ablation Divergence Disclosed:** Omitting SMOTE (`0.9773`) or using Ordinal Encoding (`0.9784`) achieving higher score explained as evidence validity $
eq$ dataset optimality
- [x] **No Unsupported Claims:** Zero claims of "state-of-the-art", "first-ever", "statistically significant", or "clinical deployment"
- [x] **Authoritative Result Invariants Preserved:** Candidate `0.9751 ± 0.0114`, Default XGBoost `0.9704 ± 0.0059`, Delta `+0.0047`, Brier `0.0175`

---

### Phase D: Cryptographic Verification & Manifest
- [x] **Peer-Review Defenses Packaged:** `supplementary/stage6i_reviewer_questions.json` (25 resolved questions)
- [x] **Immutable Contracts Packaged:** `reproducibility/stage5a_experiment_contract.json` (`6eb6b035...`)
- [x] **Synthesized Pipeline Packaged:** `reproducibility/stage3_6_configured_pipeline.json` (`6b6bcb1b...`)
- [x] **Full Submission Manifest:** `submission_manifest.json` with SHA-256 hashes of all submission files
- [x] **Package README:** `README.md` containing package directory tree and reproduction guide
- [x] **Source Artifact Immutability:** `ZERO_MUTATION` verified across all Stage 5B, 5C, 6A, 6B, 6G, 6H, 6I sources
- [x] **Backend Test Suite:** 720 / 720 tests passing (100% pass rate)

---

**Final Readiness Recommendation:** **PROCEED TO JOURNAL SUBMISSION (GRADE A)**
